Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Io Biotech, Inc. (IOBT) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Io Biotech, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1865494.
Total stock buying since 2021: $73,989,024.
Total stock sales since 2021: $1,889,739.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 15,000 | $20,880 | 0 | $0 | 0 | $0 |
| 2024 | 0 | $0 | 1,392,618 | $1,889,739 | 0 | $0 |
| 2023 | 5,662,029 | $11,068,146 | 0 | $0 | 0 | $0 |
| 2021 | 4,492,857 | $62,899,998 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 15,000 | $20,880 | 0 | $0 | 0 | $0 |
| 2024-07 | 0 | $0 | 75,000 | $99,097 | 0 | $0 |
| 2024-05 | 0 | $0 | 658,809 | $802,429 | 0 | $0 |
| 2024-02 | 0 | $0 | 658,809 | $988,213 | 0 | $0 |
| 2023-11 | 10,000 | $10,125 | 0 | $0 | 0 | $0 |
| 2023-08 | 5,627,029 | $10,999,996 | 0 | $0 | 0 | $0 |
| 2023-03 | 25,000 | $58,025 | 0 | $0 | 0 | $0 |
| 2021-11 | 4,492,857 | $62,899,998 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-30 | Hunter Heidi | Buy | 15,000 | 1.39 | 20,880 |
| 2024-07-26 | Novo Holdings A/s | Sale | 23,478 | 1.31 | 30,779 |
| 2024-07-25 | Novo Holdings A/s | Sale | 51,522 | 1.33 | 68,318 |
| 2024-05-10 | Novo Holdings A/s | Sale | 658,809 | 1.22 | 802,429 |
| 2024-02-09 | Novo Holdings A/s (10% Owner) | Sale | 658,809 | 1.50 | 988,213 |
| 2023-11-22 | Burkavage Brian (Chief Accounting Officer) | Buy | 5,000 | 1.03 | 5,175 |
| 2023-11-21 | Burkavage Brian (Chief Accounting Officer) | Buy | 5,000 | .99 | 4,950 |
| 2023-08-09 | Vivo Opportunity Fund Holdings, L.p. | Buy | 3,157,894 | 1.90 | 5,999,998 |
| 2023-08-09 | Novo Holdings A/s (10% Owner) | Buy | 2,469,135 | 2.02 | 4,999,998 |
| 2023-03-17 | Sullivan Amy (Chief Financial Officer) | Buy | 25,000 | 2.32 | 58,025 |
| 2021-11-09 | Malier Vanessa | Buy | 325,000 | 14.00 | 4,550,000 |
| 2021-11-09 | Andersson Claus A. | Buy | 75,000 | 14.00 | 1,050,000 |
| 2021-11-09 | Vivo Capital Fund Ix, L.p. | Buy | 650,000 | 14.00 | 9,100,000 |
| 2021-11-09 | Nielsen Jack | Buy | 650,000 | 14.00 | 9,100,000 |
| 2021-11-09 | Lundbeckfond Invest A/s | Buy | 2,142,857 | 14.00 | 29,999,998 |
| 2021-11-09 | Novo Holdings A/s (10% Owner) | Buy | 325,000 | 14.00 | 4,550,000 |
| 2021-11-09 | Hbm Healthcare Investments (cayman) Ltd. | Buy | 325,000 | 14.00 | 4,550,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of IOBT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Io Biotech, Inc. (symbol IOBT, CIK number 1865494) see the Securities and Exchange Commission (SEC) website.